Report / Trial registry metadata
PET Scanning in Parkinson s Disease
This study concerns Schizophrenia, Parkinson's Disease. Its registered status is completed. The planned measures below describe the study design, not demonstrated treatment effects.
What is being studied?
- Conditions
- Schizophrenia, Parkinson's Disease
- Study type
- Observational
How is the study designed?
- Enrollment
- 502 (actual)
- Minimum age
- 18 Years
- Maximum age
- 90 Years
- Eligibility sex
- All
Which interventions are listed?
- Drug: O-15 Water
- Drug: 18F-Fluoro-L-dopa
What will the study measure?
- To explore with positron emission tomography (PET) the pathophysiology and cerebral consequences of dopaminergic dysregulation. Assessment window: Ongoing
What can this record establish?
These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.
- Kind
- Trial registry metadata
- Identifier
- NCT00024622
- Status
- COMPLETED